Skip to product information
1 of 1

PT-141 10mg

PT-141 10mg

Regular price $50.00
Sale price $50.00 Regular price $80.00
SAVE 37% Sold out

PT-141 10mg

Regular price $50.00
Sale price $50.00 Regular price $80.00
SAVE 37% Sold out

Get it as soon as -

30 Day Trial

We're confident you'll be happy with your order! In case things don't go as planned, you have 30 days to request a refund based on our return and refund policy.

Shipping & Processing

Our shipping services are designed to be fast and reliable, ensuring your order is delivered promptly. Please allow 5-10 business days for delivery.

Track My Order

Once your order is shipped, we will provide you with a tracking number to monitor the progress of your shipment on our website or the shipping carrier's website. You can track your order here Track My Order

PT-141 (Bremelanotide) is a peptide used to treat sexual dysfunction. FDA-approved as Vyleesi, it treats hypoactive sexual desire disorder (HSDD) in women and is also studied for erectile dysfunction (ED). Unlike Viagra, it works by stimulating the melanocortin system in the brain to enhance arousal. Administered via injection, effects start within 30-60 minutes and last 6-12 hours. Side effects include nausea, flushing, headaches, and increased blood pressure.

Add 1mL of bacteriostatic water to get a solution that is 10mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 1mg of PT-141.
This product must be refrigerated after reconstitution.
View full details

01The PureChain Standard

Purity And Documentation

Your results are only as good as the compound you start with.

Every vial is labelled with its compound, vial size and molecular weight, and ships for laboratory research use only. Third-party testing details will be published here.

Supplied for in-vitro laboratory research only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.

Size
10mg
Form
Lyophilized powder
Storage
−20 °C, protected from light
Molar mass
1025.2 Da

About This Compound

About PT-141

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide derived directly from Melanotan II. Where Melanotan II ends in an amide, PT-141 carries a free carboxylic acid at the same position, and that single change shifts the molecule away from the pigmentation receptor and towards the central melanocortin receptors. It is used in research as a comparatively selective melanocortin probe, and it is the compound that established that melanocortin signalling in the brain, rather than the vascular system, sits behind a distinct arousal pathway.

Cyclic Heptapeptide Melanocortin Receptor Agonist

Molecular Formula

C50H68N14O10

Molecular Weight

1025.2 g/mol

Form

Lyophilized Powder

CAS Number

189691-06-3

02Molecular Structure

The PT-141 molecule

An illustrative atomic representation generated from the compound record, alongside its verified molecular data. The structure figure is schematic – not a measured conformation.

  • C
  • H
  • N
  • O
  • S/P
Molecular Formula C50H68N14O10
Molecular Weight 1025.2 g/mol
Sequence Length 7 residues
Chemical Name Bremelanotide (PT-141)
Physical Form Lyophilized Powder
CAS Number 189691-06-3
Use Class Research use only

Molecular data from the public PubChem record (CID 9941379). View on PubChem

By The Numbers

PT-141 Research, By The Numbers

The figures that define PT-141 and how it is being studied. For laboratory research use only.

7

Amino Acids

Cyclic heptapeptide, the des-amide metabolite of Melanotan II

MC4R

Primary Receptor Target

Acts mainly at the central melanocortin-4 receptor

1990s

Period First Described

Identified during melanocortin work that followed Melanotan II

4

Research Areas

  • Central Arousal Pathways
  • Melanocortin Receptor Pharmacology
  • Neuroendocrine Signalling
  • Structure-Activity Research

How It Works

How PT-141 Works

The pathways PT-141 acts on, and what each one does. Described from preclinical and receptor-pharmacology literature.

MC4R Agonism

Central Melanocortin-4 Signalling

PT-141 activates MC4R, a G protein-coupled receptor concentrated in the hypothalamus and other central nervous system regions. Activation raises intracellular cAMP in those neurons, which is the signalling step researchers measure when mapping melanocortin circuitry.

  • Agonist at the melanocortin-4 receptor
  • Signals through adenylyl cyclase and cAMP
  • Central rather than peripheral site of action
Pathway Distinction

A Non-Vascular Arousal Pathway

The research interest in PT-141 comes from where it does not act. Unlike PDE5-targeting compounds, it does not work on vascular smooth muscle, so preclinical studies using it separate centrally-mediated arousal signalling from blood-flow mechanisms.

  • Does not act on the nitric oxide / cGMP vascular pathway
  • Used to isolate central from peripheral mechanisms
  • Studied in models where vascular agents show no effect
Receptor Selectivity

Selectivity Against Melanotan II

Melanotan II activates MC1R through MC5R broadly. PT-141 retains potency at MC3R and MC4R while binding MC1R far more weakly, which is why the two compounds are routinely compared side by side in structure-activity work.

  • Markedly reduced MC1R activity versus Melanotan II
  • Retains MC3R and MC4R agonism
  • The C-terminal acid, not the peptide ring, drives the shift

Signalling pathways studied in preclinical models. Illustrative, not a claim of effect in humans.

Uses And Applications

What PT-141 Is Researched For

The main areas PT-141 is studied in, and the qualitative magnitudes reported alongside them.

Central Arousal Pathway Models

The primary research use. PT-141 is the standard tool compound for probing melanocortin-mediated arousal circuitry in preclinical models, because its central site of action separates that pathway from vascular mechanisms.

Melanocortin Receptor Pharmacology

Used in binding and functional assays across the MC1R to MC5R family to characterise what selectivity a C-terminal modification buys, and what it costs.

Structure-Activity Research

PT-141 and Melanotan II differ by one terminal group, which makes the pair a clean case study in how a minimal change redirects a peptide across a receptor family.

Neuroendocrine Signalling

Applied in work on hypothalamic signalling, where MC4R sits in circuits involving feeding behaviour, energy balance and autonomic output.

Study-Reported Magnitudes

Qualitative summaries of published research. Bars fill as you scroll.

MC4R Agonist Potency High
MC1R Activity vs Melanotan II Much Lower
Central Nervous System Site Of Action Established
Vascular Pathway Involvement Not Observed

Figures are representative summaries of published research findings, shown for reference only. They are not claims about outcomes in humans.

Compound Information

Full Specification

Chemical Name Bremelanotide (PT-141)
Sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
Molecular Weight 1025.2 Da
Molecular Formula C50H68N14O10
CAS Number 189691-06-3
Form Lyophilized powder
Solubility Water-soluble
Storage Store lyophilized at −20 °C, protected from light and moisture
Vial Size 10mg
PubChem CID 9941379

FAQ

Common Questions About PT-141

What Is PT-141?

PT-141, or bremelanotide, is a synthetic cyclic heptapeptide and a melanocortin receptor agonist. It is a chemical derivative of Melanotan II and is supplied here strictly as a research compound.

How Does PT-141 Differ From Melanotan II?

Chemically, by one group: Melanotan II ends in a C-terminal amide and PT-141 in a free acid. Pharmacologically that shifts it away from MC1R, the pigmentation receptor, while it keeps its activity at the central MC3R and MC4R receptors.

Why Is PT-141 Studied Separately From Vascular Compounds?

Because it acts centrally. PDE5-targeting compounds work on the nitric oxide and cGMP pathway in vascular smooth muscle; PT-141 does not, so preclinical work with it isolates a nervous-system pathway rather than a blood-flow one.

Is PT-141 Approved For Human Use?

Nothing supplied by PureChain Labs is approved for human use or sold for it. This material is supplied as a research chemical for in-vitro laboratory work only, and the regulatory status of any bremelanotide product elsewhere has no bearing on that.

What Is The Melanocortin System?

A family of five G protein-coupled receptors, MC1R through MC5R, that respond to endogenous ligands including alpha-MSH. Between them they sit behind pigmentation, energy balance, inflammation and arousal signalling.

How Should Research-Grade PT-141 Be Stored?

Lyophilized PT-141 should be kept at −20 °C, protected from light and moisture, and refrigerated once reconstituted. The cyclic backbone is relatively robust, but the powder should still be stored cold and dry until it is used.

Feedback

WHAT OUR CUSTOMERS HAVE TO SAY...

"Been using PureChain Labs for 9 months now. In my opinion, it's the best source in Canada. Quality product every time and gives me the best results. Also the communication is second to none, I get a response in minutes usually. Overall extremely happy with the service and product they provide."
Mike C.
"A+ service and communication. Delivery is always quick and packaged safe and sound... I love how they are transparent and you know what your getting and for using a new source for the first time that's a huge relief."
Jennifer M.
"Took a month but hair felt thicker at roots, gave me hope after months of thinning, they definitely sell quality peptides."
Melissa P.
Research Use Only

Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA or Health Canada; this product is not intended to diagnose, treat, cure or prevent any disease.